Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion
Jason D.Whitt
Adam B.Keeton
Bernard D.Gary
Larry A.Sklar
Kamlesh Sodani
Zhe-Sheng Chen
Gary A.Piazza
Keywords：multi-drug resistancedoxorubicinsulindacMRP1glutathione
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)